Medical Marijuana, Inc., the world’s first publicly listed cannabis firm to introduce cannabis-derived nutraceutical goods, brands, and supply chain, announced today that its subsidiary, Kannaway, has begun operations in Hong Kong.
“Our initial Asian expansion in Japan was a huge success, and we’re excited to introduce our high-quality cannabidiol (CBD) products to Hong Kong as well,” says the company.
According to Kannaway® CEO Blake Schroeder.
“Hemp has a long history in the region, and China is the world’s top hemp grower, according to MJBizDaily.
Now that CBD is becoming more popular throughout the world, Hong Kong residents who wish to reconnect with their origins are turning to hemp-derived CBD.”
Kannaway® will conduct regional events to educate existing and future Brand Ambassadors on the numerous health and financial benefits of hemp-derived CBD oil.
Kannaway® is a network sales and marketing firm that specializes in selling hemp-based botanical goods.
Kannaway® conducts monthly sales meetings and conferences across the world, providing sales professionals with unique insight and opportunities to become effective leaders in the selling and marketing of hemp-based botanical products.